Sanjeev R. Phatak
Ahmedabad, UP, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes: Findings from PIONEER REAL India.
Journal: Indian journal of endocrinology and metabolism
Published: April 25, 2025
Consensus to Reduce Withdrawal and Improve Adherence with SGLT2i: Consensus TWO SGLT2i Adherence Group.
Journal: The Journal of the Association of Physicians of India
Published: April 09, 2025
Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India.
Journal: BMC endocrine disorders
Published: February 22, 2025
Ahmedabad declaration: A framework to combat growing epidemic of young-onset type 2 diabetes in Asia.
Journal: Diabetes & metabolic syndrome
Published: February 02, 2025
Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-An expert consensus statement from Indian diabetologists' perspective.
Journal: Diabetes, obesity & metabolism
Published: January 17, 2025
A Multicenter, Retrospective Study to Evaluate the Effectiveness and Safety of Imeglimin in Patients with Type 2 Diabetes Mellitus in a Real-World Clinical Setting (INDI-TIMES Study).
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: October 16, 2024
Leveraging the use of a social media app as a collaborative medical information and knowledge sharing tool-insights from experiential use and survey of a CME WhatsApp community.
Journal: BMC medical education
Published: November 05, 2023
Sodium-glucose Cotransporter-2 Inhibitors in Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus: A Meta-analysis.
Journal: The Journal of the Association of Physicians of India
Published: September 09, 2022
One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India-TRUST (Tresiba real-world use study).
Journal: Metabolism open
Published: February 14, 2022
Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study.
Journal: Diabetes & metabolic syndrome
Published: January 31, 2022
Last Updated: 09/26/2026